IRWD: Ironwood Pharmaceuticals, Inc. Class A
Performance
IRWD +143.75%
Watchlist
Select an item
Summary
IRWD at a glance
IRWD returned +143.75% over the past year and -18.31% a year over five years. Its worst drop in that year was -43.60%, smaller than 32% of stocks on Redstone, and its Sharpe ratio of 1.41 beats 89% of stocks on Redstone. It pays no dividends.
Current Drawdown
-13.17%
Rolling Volatility
64.67%
Actions
Metrics
Risk Indicators
Alpha106.17%
Beta1.55x
Sharpe1.41
Sortino2.52
Omega1.29
Calmar3.30
Martin4.83
Profile
About IRWD
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $773M
- Listed
- Feb 2010
- Employees
- 100
- Headquarters
- Boston, MA
- Website
- ironwoodpharma.com
Comparisons